European Parliament
Maria do Céu Patrão Neves  (PPE ),
in writing.
(PT)
While I would warn that the Innovative Medicines Initiative (IMI) should communicate to the discharge authority the measures adopted, with their implementation timeframe, to address the recommendations of the interim review and to provide regular updates on the progress achieved, I voted to approve the accounts submitted by the European Commission, thereby granting the IMI discharge for its 2010 accounts.

